Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...

-- 30.2-month median progression-free survival with a median follow-up of 38.1 months in the Phase 1 study of anito-cel; median overall survival not reached -- -- Preliminary results from 58 patients ...

India’s multi-crore Bullet Train project is delayed following non –availability of trains from Japan, and late tendering. This has been established in multiple documents, including a progress report ...

At a time when cancer research is experiencing uncertainty and setbacks, the Colorectal Cancer Alliance (Alliance) is strengthening its commitment to its Project Cure CRC initiative because tomorrow ...

Mayor Burgueño will share his first Results Report, offering residents a look at the progress made during his first year in ...